Brady (BRC) Q1 2025 earnings summary

Executive summary

• Sales grew 13.6% year-over-year to $377.1 million, with organic growth of 3.6%, acquisitions contributing 8.8%, and currency adding 1.2%.

• Adjusted pre-tax earnings rose 11% to $68.6M, and adjusted diluted EPS increased 12% to $1.12.

• Americas and Asia regions led with 5.1% organic sales growth; Europe and Australia returned to growth.

• Acquisitions of Gravotech and AB&R expanded product offerings and contributed to sales growth.

• Net income was $46.8 million, nearly flat compared to $47.2 million in the prior year.

Financial highlights

• Gross margin was $189.7 million (50.3% of sales), down from 51.7% last year due to nonrecurring inventory adjustments; adjusted gross margin was 51.4%.

• Operating income was $58.9 million, down 1.4% year-over-year, mainly due to acquisition-related and nonrecurring costs.

• Adjusted net income increased 10.4% to $54.2 million.

• Cash and cash equivalents were $145.7 million at quarter-end, down from $250.1 million at the prior fiscal year-end, mainly due to acquisition spending.

• Net cash provided by operating activities was $23.4 million, down from $62.3 million last year.

Outlook and guidance

• Maintained full-year adjusted diluted EPS guidance of $4.40–$4.70 and GAAP EPS guidance of $4.02–$4.32.

• Expect low single-digit organic sales growth for fiscal 2025.

• Guidance assumes a 20% tax rate, $40M in depreciation/amortization, and $35M in capex.

• Financial resources and liquidity are considered sufficient to support growth strategy and manage potential economic or geopolitical impacts.